Balyasny Asset Management’s Protalix BioTherapeutics PLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-76,063	Closed	-$195K	–	2370
2025 Q1	$195K	Buy	+76,063	New	+$195K	﹤0.01%	1821
2024 Q3	–	Sell	-13,299	Closed	-$15.6K	–	2271
2024 Q2	$15.6K	Buy	+13,299	New	+$15.6K	﹤0.01%	1845